Enacts the "New York affordable drug manufacturing act"
Summary
Enacts the "New York affordable drug manufacturing act" to direct the commissioner of health to enter into partnerships to increase competition, lower prices, and address shortages in the market for generic prescription drugs, to reduce the cost of prescription drugs for public and private purchasers, taxpayers, and consumers, and to increase patient access to affordable drugs.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jan 2025
Committee Review
Floor Vote
Governor
Introduced Jan 27, 2025
Last action Jan 7, 2026
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
2
Jan 7, 2026
Committee
REFERRED TO HEALTH
lower
Jan 27, 2025
Committee
REFERRED TO HEALTH
lower
1 primary · 11 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Jenifer Rajkumar
DDemocratic
Co
Angelo Santabarbara
DDemocratic
Co
Jeffrey Dinowitz
DDemocratic
Co
JG
Jessica González-Rojas
DDemocratic/Working Families
Co
Jo Anne Simon
DDemocratic
Co
Judy Griffin
DDemocratic
Co
Linda Rosenthal
DDemocratic
Co
Phara Souffrant Forrest
DDemocratic
Co
Phil Steck
DDemocratic
Co
Rebecca Seawright
DDemocratic
Co
Steve Stern
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about A 3236
Scope: NY
Hi! I can help you understand A 3236. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline